Literature DB >> 1528642

Reduced measles immunity in infants in a well-vaccinated population.

H F Pabst1, D W Spady, R G Marusyk, M M Carson, L W Chui, M R Joffres, K M Grimsrud.   

Abstract

The recommended age for measles vaccination is based in part on information gathered when most mothers had natural measles. Nowadays many mothers have received measles vaccine. To assess this change measles antibody neutralization titers (NT) were determined for 278 mother-infant pairs. One hundred sixty-four mothers, born before 1958, likely had had natural measles (Group 1). Sixty mothers received one to three killed plus one attenuated measles vaccination (Group 2) and 54 received 1 attenuated measles vaccination only (Group 3). NT were determined for the mother and for the infant at birth and in the infant during the fourth and sixth months. Group 1 mothers and infants at every age had higher geometric mean NT than those in Groups 2 or 3 (P less than 0.05). By 7 months 65% of Group 1 infants and greater than 90% of Group 2 and 3 infants had an NT less than 1:10. The rate of antibody decay was significantly faster for Group 1 infants (P less than 0.05). Earlier vaccination in the infant should be considered.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528642     DOI: 10.1097/00006454-199207000-00004

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  13 in total

1.  Pre-vaccination evolution of antibodies among infants 0, 3 and 6months of age: A longitudinal analysis of measles, enterovirus 71 and coxsackievirus 16.

Authors:  Chuanxi Fu; Jichuan Shen; Long Lu; Yajing Li; Yimin Cao; Ming Wang; Sen Pei; Zhicong Yang; Qing Guo; Jeffrey Shaman
Journal:  Vaccine       Date:  2017-06-10       Impact factor: 3.641

2.  Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.

Authors:  P Plans; F de Ory; M Campins; E Álvarez; T Payà; E Guisasola; C Compte; K Vellbé; C Sánchez; M J Lozano; I Aran; A Bonmatí; R Carreras; M Jané; L Cabero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-10       Impact factor: 3.267

3.  Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.

Authors:  C Nicoara; K Zäch; D Trachsel; D Germann; L Matter
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.

Authors:  Sulachni Chandwani; Judy Beeler; Hong Li; Susette Audet; Betsy Smith; John Moye; David Nalin; Keith Krasinski
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

5.  Measles vaccination policy.

Authors:  B G Williams; F T Cutts; C Dye
Journal:  Epidemiol Infect       Date:  1995-12       Impact factor: 2.451

6.  Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.

Authors:  Shaikh Meshbahuddin Ahmad; Jahangir Alam; Nure Alam Afsar; Nazmul Huda; Yearul Kabir; Firdausi Qadri; Rubhana Raqib; Charles B Stephensen
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

7.  A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women.

Authors:  R Brugha; M Ramsay; T Forsey; D Brown
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

8.  Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Authors:  Arnaud Gagneur; Didier Pinquier; Marie Aubert; Laurent Balu; Olivier Brissaud; Loïc De Pontual; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Jean-Louis Stephan; Bernard Cohen; Evelyne Caulin; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

9.  Measles outbreak in South Africa: epidemiology of laboratory-confirmed measles cases and assessment of intervention, 2009-2011.

Authors:  Genevie M Ntshoe; Johanna M McAnerney; Brett N Archer; Sheilagh B Smit; Bernice N Harris; Stefano Tempia; Mirriam Mashele; Beverley Singh; Juno Thomas; Ayanda Cengimbo; Lucille H Blumberg; Adrian Puren; Jocelyn Moyes; Johann van den Heever; Barry D Schoub; Cheryl Cohen
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Measles elimination and immunisation: national surveillance trends in Japan, 2008-2015.

Authors:  S Inaida; S Matsuno; F Kobune
Journal:  Epidemiol Infect       Date:  2017-06-23       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.